CVRx brings Michael Dale onto board to leverage leadership in medical devices

CVRx brings Michael Dale onto board to leverage leadership in medical devices
CVRx adds Michael Dale to board

CVRx has appointed Michael Dale as a new member of its Board of Directors.

Dale brings decades of leadership experience in the medical device sector and is known for a strong track record in driving growth and innovation. The company expressed confidence that his insights and strategic guidance will benefit its board and overall strategy moving forward.

CVRx has recently marked the completion of 50 Barostim implants at Wellstar Kennestone, advancing its presence in heart failure treatment options, according to a company announcement. The company is also focusing on clinical integration with plans to host a Barostim symposium at AAHFN2026 for advanced practice providers, as stated in an earlier update. These initiatives reflect ongoing efforts to expand Barostim adoption.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.